VanEck Biotech Three Year Return vs. Price to Sales

BBH Etf  USD 151.99  1.02  0.67%   
Considering the key profitability indicators obtained from VanEck Biotech's historical financial statements, VanEck Biotech ETF may not be well positioned to generate adequate gross income at the present time. It has a very high likelihood of underperforming in May. Profitability indicators assess VanEck Biotech's ability to earn profits and add value for shareholders.
For VanEck Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of VanEck Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well VanEck Biotech ETF utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between VanEck Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of VanEck Biotech ETF over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

VanEck Biotech ETF Price to Sales vs. Three Year Return Fundamental Analysis

VanEck Price to Sales vs. Three Year Return

Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.

VanEck Biotech

Three Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
(5.90) %
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.

VanEck Biotech

 = 
null

Use VanEck Biotech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VanEck Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will appreciate offsetting losses from the drop in the long position's value.

VanEck Biotech Pair Trading

VanEck Biotech ETF Pair Trading Analysis

The ability to find closely correlated positions to VanEck Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VanEck Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VanEck Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VanEck Biotech ETF to buy it.
The correlation of VanEck Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VanEck Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VanEck Biotech ETF moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VanEck Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your VanEck Biotech position

In addition to having VanEck Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Restaurants Thematic Idea Now

Restaurants
Restaurants Theme
Entities that are involved in restaurant business, as well as coffee shop chains and other eateries. The Restaurants theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaurants Theme or any other thematic opportunities.
View All  Next Launch
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out Trending Equities.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
To fully project VanEck Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of VanEck Biotech ETF at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include VanEck Biotech's income statement, its balance sheet, and the statement of cash flows.
Potential VanEck Biotech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although VanEck Biotech investors may work on each financial statement separately, they are all related. The changes in VanEck Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VanEck Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.